An ISA-TAB-Nano based data collection framework to support data-driven modelling of nanotoxicology by Robinson, RLM et al.
Page 1 
 
An ISA-TAB-Nano based data collection framework 
to support data driven modelling of nanotoxicology 
Richard L. Marchese Robinson1, Mark T. D. Cronin*1, Andrea-Nicole Richarz1, Robert 
Rallo2 
Address:  
1 School of Pharmacy and Biological Sciences, Liverpool John Moores University, 
James Parsons Building, Byrom Street, Liverpool, L3 3AF, United Kingdom  
2 Departament d'Enginyeria Informatica i Matematiques, Universitat Rovira i Virgili, 
Av. Paisos Catalans 26, 43007 Tarragona, Catalunya, Spain  
Email: Mark T.D. Cronin (M.T.Cronin@ljmu.ac.uk) 
* Corresponding author 
Abstract 
Analysis of trends in nanotoxicology data and the development of data driven models 
for nanotoxicity is facilitated by the reporting of data using a standardised electronic 
format. ISA-TAB-Nano has been proposed as such a format. However, in order to 
build useful datasets according to this format, a variety of issues have to be 
addressed. These issues include questions regarding exactly which (meta)data to 
report and how to report them. The current article discusses some of the challenges 
associated with the use of ISA-TAB-Nano and presents a set of resources designed 
to facilitate the manual creation of ISA-TAB-Nano datasets from the nanotoxicology 
literature. These resources were developed within the context of the NanoPUZZLES 
EU project and include data collection templates, corresponding business rules which 
extend the generic ISA-TAB-Nano specification as well as Python code to facilitate 
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parsing and integration of these datasets within other nanoinformatics resources. The 
use of these resources is illustrated by a “Toy Dataset” presented in the Supporting 
Information. The strengths and weaknesses of the resources are discussed along 
with possible future developments. 
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Introduction 
Nanotechnology, which may be considered the design and application of engineered 
nanomaterials with desired properties [1,2], is of increasing importance [3,4]. 
Nanomaterials may be considered to be any chemicals with (a majority of) 
constituent particles with one or more dimensions in the nanoscale (typically 1-100 
nm) range and engineered nanomaterials may be considered to be any 
nanomaterials which are intentionally produced. (It should be noted that slightly 
different definitions of these terms have been proposed by different organisations [1]  
and the European Commission has recommended a specific definition of a 
“nanomaterial” for legislative and policy purposes within the European Union [5].) 
Nanomaterials have been used and/or have been investigated for use in a diverse 
range of applications such as sunscreens, cosmetics, electronics and medical 
applications [2,4,6,7]. In addition to interest in the benefits offered by 
nanotechnology, concerns have also been raised about the potential risk posed by 
nanomaterials to human health and the environment [3,4,7]. Various research 
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initiatives have been (and are being) funded to advance scientific understanding of 
nanotechnology and nanosafety and to enable the appropriate selection, design and 
regulation of nanomaterials for technological applications [3,8,9]. There is a particular 
interest in the possibility of using computational approaches as part of the safety 
assessment of nanomaterials e.g. to enable “safety by design” [3,7,9,10]. 
Experimental data are critical to advancing understanding of the properties of 
nanomaterials and the ability to design nanomaterials with desirable technological 
properties and acceptable safety profiles [2,9–11]. In order to enable “safety by 
design”, data from toxicity studies need to be related to relevant 
structural/physicochemical data [10], where the latter may include information on 
chemical composition as well as a range of other measured properties such as size 
distribution statistics and zeta potential, to name but two [12]. Being able to relate 
these data allows for the development of predictive models based on quantitative 
structure activity relationships (QSARs) for nanomaterials  - so-called quantitative 
nanostructure-activity relationships (“QNARs”) [10] or “nano-QSARs” [13] – as well as 
“category formation” and “read-across” predictions [9,14,15]. 
In order to make most effective use of these data, experimental datasets should be 
made available via a standardised, electronic format that facilitates meaningful 
exchange of information between different researchers, submission to (web-based) 
searchable databases, integration with other electronic data resources and analysis 
via appropriate (modelling) software [9,16–18]. This could entail directly populating 
files based on a standardised format or direct entry of data into searchable 
databases using a (web-based) data entry tool [19], followed via data 
export/exchange in a standardised format. However, in contrast to directly populating 
standardised, structured files (such as spreadsheets), direct entry of data into (web-
based) searchable databases may not be possible for domain experts (e.g. 
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nanotoxicologists in experimental labs) with little or no informatics support: these 
researchers may not have their own, in-house database system and data entry to a 
third party database at the point of data collection may not be practical. Data 
collected using standardised, structured files may be readily, programatically 
submitted to (web-based) searchable databases at a later stage in the research 
cycle.  
Standardised, structured files also facilitate programmatic analysis (i.e. entirely new 
codes do not need to be developed for each new dataset) for the purposes of 
computational modelling. They also enable integration between datasets, partly due 
to the ease of programmatic analysis and in part because standardisation makes it 
clearer when two items of (meta)data in distinct datasets are related. Data integration 
within searchable databases supports computational modelling via enabling data 
from multiple sources to be combined, in principle, for more robust, generalisable 
analysis and via facilitating the identification of data which are relevant to a given 
modeller’s needs. 
Regarding the nature of these standardised, structured files, whilst more complicated 
file formats based on the eXtended Markup Language (XML) or the Resource 
Description Framework (RDF) might be considered, a spreadsheet-based file format 
offers a key advantage: most scientists are likely to be familiar with creating, editing 
and viewing spreadsheet-based datasets [17,20,21]. Indeed, these kinds of files can 
be edited and viewed using widely used, non-specialist software (such as Microsoft 
Excel), whilst (to some extent) a spreadsheet-like interface may be retained within 
specialist software designed to ensure the files are compliant with the rules of a 
standardised specification [17,20,22]. However, no claim is being made as to the 
intrinsic optimality of a spreadsheet-based format: a detailed discussion of the 
advantages and disadvantages of different file formats is beyond the scope of the 
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current publication and interested readers are referred to the cited literature and the 
references therein [17,20,21]. 
The ISA-TAB-Nano specification, comprising a set of interrelated spreadsheet-based 
tabular file types, was recently proposed as a solution to the requirement for a 
standardised, electronic format for nanomaterial data [16,17,23]. However, as well as 
a general specification specifying how different kinds of (meta)data should be 
recorded in a standardised fashion, additional requirements for nanotoxicology 
datasets to be most valuable for analysis of trends and development of data driven 
models exist. These requirements include the need to report the necessary 
physicochemical parameters, experimental details and other relevant metadata such 
as provenance [12,24–27]. Whilst the generic ISA-TAB-Nano specification [17,23] 
specifically calls for relevant provenance information to be provided, and facilitates 
presentation of other (meta)data, it does not specify all of the (meta)data which 
should be recorded nor exactly how these (meta)data should be presented. 
The current article presents a set of resources which were designed for manually 
harvesting data from the published literature to create ISA-TAB-Nano datasets in 
order to support analysis and modelling of nanotoxicology data, including the 
integration of these data within online, searchable databases. Specifically, these 
resources are as follows: a collection of Excel templates for creating ISA-TAB-Nano 
files containing specific, relevant (meta)data manually harvested from the scientific 
literature; a corresponding set of business rules for populating these templates which 
build upon the generic ISA-TAB-Nano specification; a Python program for converting 
the resulting ISA-TAB-Nano files to tab-delimited text files to facilitate computational 
analysis and database submission. Since there is a growing interest in the use of 
ISA-TAB-Nano as a community standard for organising for nanomaterial data, from a 
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variety of individual researchers and organizations [3,28–32], it is anticipated that 
these resources will be of value for the research community. 
These resources were developed within the context of the NanoPUZZLES project 
[33], but their development was informed via discussions with various researchers in 
the nanoinformatics/nanotoxicology community and consideration of various 
complementary nanoinformatics resources such as those developed within the 
MODERN [34] and eNanoMapper [35] projects. 
The rest of the article is organised as follows. “Section 1” of “Results and Discussion” 
provides a brief overview of the generic ISA-TAB-Nano specification. “Section 2” 
summarises some challenges associated with the use of this generic specification 
(especially when used to collect data from the literature) which the current work 
sought to address. “Section 3” summarises the data collection templates and the 
basis on which they were developed. “Section 4” summarises the new business rules 
which were created for populating these templates. “Section 5” provides an overview 
of the Python program written to facilitate analysis and databases submission of 
datasets created using these templates. “Section 6” presents a “Toy Dataset” created 
using these templates. “Section 7” presents a critical appraisal of the developed 
resources, discusses links to related research initiatives and resources along with 
possible future directions for this work. The “take home” messages of this article are 
summarised under “Conclusion”. The challenges, business rules and notable 
limitations of the presented resources (summarised in sections 2, 4 and 7 
respectively) are fully explained in the Supporting Information. 
The resources described in this article, along with the “Toy Dataset”, are publicly 
available under open licenses (see “Supporting Information”). 
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Results and Discussion  
Section 1. A Brief Overview of the Generic ISA-TAB-Nano 
Specification 
The ISA-TAB-Nano specification [17,23] extends the ISA-TAB specification 
[18,20,22,36] which was previously proposed as an exchange standard for biological 
data and metadata based on a standardised metadata representation. Unless noted 
otherwise, the specification incorporates [17,23] all the business rules (e.g. 
restrictions on which fields can hold multiple values) associated with the original ISA-
TAB specification [36]. The official ISA-TAB-Nano wiki [23] provides the most up to 
date information regarding the generic ISA-TAB-Nano specification, including 
detailed descriptions [37–40] and Excel templates for each of the file types described 
below. Since the original description of the specification in Thomas et al. [17], two 
revisions (version 1.1 and version 1.2) of the specification had published on the wiki 
at the time of writing. The overview provided in the current paper refers to version 1.2 
of ISA-TAB-Nano. Since the specification is extensively described elsewhere [17,23], 
the following overview focuses on the essential background required to understand 
the following sections of the current paper. 
The ISA-TAB-Nano specification describes a set of four linked file types 
(Investigation, Study, Assay, Material), each of which is a spreadsheet-like table, 
which are used to record different kinds of (meta)data associated with a given 
“Investigation”, which may be considered to correspond to a set of different kinds of 
experimental studies carried out on a given set of nanomaterials [36]. In addition, the 
specification describes corresponding business rules governing how these files can 
be populated. A given “Investigation” is associated with a single Investigation file and, 
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potentially, multiple Study, Assay and Material files. The kinds of (meta)data each file 
type is designed to record and the links between different kinds of files is summarised 
in Figure 1 and discussed in more detail below.  
Investigation file 
The Investigation file [37] reports key metadata describing the terms used in the other 
files as well as reporting overall conclusions derived from the “Investigation”, if any.  
Material file 
Each of the nanomaterial samples (implicitly as originally sourced for the 
“Investigation” [17]) is described by a corresponding Material file [40] associated with 
a unique identifier reported in the “Material Source Name” column and used to label 
the Material file. A Material file presents chemical composition information along with 
other descriptive information about the sample such as nominal or manufacturer 
supplied characteristics reported via end user defined “Characteristics [characteristic 
name]” columns. Since nanomaterials of diverse types (e.g. dendrimers, carbon 
nanotubes, surface coated metal oxides) may comprise different components (e.g. 
core and shell), the initial rows of the Material file are used to describe the overall 
nanomaterial sample with subsequent rows used to describe the individual 
components: the overall sample and different components are each assigned unique 
values in the “Material Name” column.  
Study file 
A Study file [38] describes the preparation of samples for measurements in some 
assay: the identifiers of prepared samples are reported in “Sample Name” columns, 
with sequentially prepared samples corresponding to identifiers in sequential “Sample 
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Name” columns, and the identifier(s) of the original material(s) from which these 
samples were prepared is (are) reported in the “Source Name” column. In principle, 
multiple “Source Name” identifiers might correspond to one or more “Sample Name” 
identifiers [36]. However, in the simplest case (as adopted in the current work), a 
single prepared sample corresponds to a single original material i.e. each row 
corresponds to a single “Source Name” and a single “Sample Name” identifier. 
Properties associated with the original material or, more specifically, a prepared 
sample may be reported via “Characteristics [characteristic name]” columns situated 
after the “Source Name” column or after the relevant “Sample Name” column 
respectively.Here, it should be noted that the properties recorded via these columns 
should not include experimental endpoints which would be reported via an Assay file 
or other information about original nanomaterial samples which would be reported via 
a Material file. 
The transformation of the original material into the prepared sample(s) corresponds 
to one or more protocols (with corresponding protocol names reported in “Protocol 
REF” columns), associated with corresponding protocol “parameters” (reported in  
“Parameter Value [parameter name]” columns), and “factors” (reported in “Factor 
Value [factor name]” columns). The concept of “parameters” refers to “variables that 
are kept constant in an assay experiment”, whilst the concept of “factors” refers to 
“variables that are changed for studying their effects on the measured endpoint” [17]. 
If the assay is biological (e.g. an in vitro cytotoxicity assay), the originally sourced 
biological material is considered the original material, with its identifier reported in the  
“Source Name” column, from which a sample is prepared for testing in an assay and 
the originally sourced nanomaterial is considered a “factor”, since the effect of adding 
this nanomaterial to the biological sample being prepared for evaluation is studied: 
the corresponding Material file identifier (“Material Source Name”) is reported in an 
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appropriate “Factor Value [factor name]” column (e.g. “Factor Value [nanomaterial]). 
If the assay measures nanomaterial physicochemical parameters (e.g. size by 
dynamic light scattering, zeta potential), the originally sourced nanomaterial sample 
is considered the original material i.e. the “Material Source Name” is reported in the 
Study file “Source Name” column. It follows that different Study files must be created 
for samples prepared for biological or physicochemical assays.  
Assay file 
An Assay file [39] links (a subset of) the prepared samples described in a given Study 
file to the experimental measurements, of a given type, obtained in a given assay. 
Each Assay file row corresponds to a given sample, with the “Sample Name” 
identifier defined in the corresponding Study file being reported in the Assay file 
“Sample Name” column. Additional columns (“Protocol REF”, “Assay Name”, 
“Parameter Value [parameter name]”, “Factor Value [factor name]”) in the Assay file 
identify the assay protocol performed and experimental details associated with the 
production of a given (set of) data point(s) obtained from that assay for a given 
sample. (Here, the concepts of “parameters” and “factors” are as defined above for 
the Study file, although Assay file “parameters” are specific to Assay file protocols 
and one may choose to report “factors” in the Assay file if they are applicable to the 
assay procedure used to generate data points for a given prepared sample [17,39].)  
The corresponding data points are presented in “Measurement Value 
[statistic(measurement name)]” columns e.g. “Measurement Value [z-
average(hydrodynamic diameter)]” for an Assay file describing dynamic light 
scattering (DLS) size measurements [41,42]. 
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External files 
“External” files [17,36], presenting additional information associated with the original 
nanomaterial samples or assay measurements, can be linked to the appropriate 
Material and Assay file respectively via additional columns and may also be included 
within the ISA-TAB-Nano dataset. 
Support for (meta)data standardisation 
The ISA-TAB-Nano specification promotes standardised reporting of (meta)data in 
the following ways. (1) It defines a certain number of fixed fields (rows in the 
Investigation file, or columns in the remaining file types). (2) It describes a syntax for 
adding additional fields of a given type e.g. “Parameter Value [parameter name]” and 
“Factor Value [factor name]”. (3) It supports links between terms added by the end 
user (e.g. a parameter name or the unit for a “Measurement Value 
[statistic(measurement name)]” column entry) and standardised definitions retrieved 
from ontologies. (An excellent introduction to ontologies can be found in the recent 
articles of Thomas et al. [2,11] along with an overview of a highly relevant example: 
the NanoParticle Ontology (NPO) [2].) (4) It supports links to standardised protocol 
documentation, for sample preparation or assay measurements, for protocol names 
reported in “Protocol REF” columns in a Study or Assay file. (The ontologies to which 
various terms are linked are defined using fields in the Investigation file, which also 
provides links between protocol names and standardised documentation.) 
As well as providing some pre-defined fields and stipulating a specific syntax for 
adding fields of a specific type (e.g. “Factor Value [factor name]”), miscellaneous 
additional fields can be created via adding new “Comment [name of (meta)data item]” 
fields if no appropriate alternative exists. 
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Figure 1: A schematic illustration of the links between ISA-TAB-Nano files. Biological 
or material samples are prepared for measurements in biological or physicochemical 
assays respectively. Assay files link measurement values with prepared sample 
identifiers (“Sample Name” values). Study files describe sample preparation. Material 
files describe the nanomaterials obtained for testing, denoted via their “Material 
Source Name” identifiers. N.B. Italic font denotes generic names e.g. “Factor Value 
[test material]” is replaced with “Factor Value [nanomaterial]” in the NanoPUZZLES in 
vitro cell-based Study file template. 
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Section 2. Challenges Associated with the Generic ISA-TAB-Nano 
Specification which were Addressed in the Current Work 
Table 1 presents some key challenges associated with the use of the generic ISA-
TAB-Nano specification (version 1.2), especially when used to collect data from the 
published literature, and which were addressed in the work reported in the current 
article. An in-depth explanation of these challenges, along with a detailed discussion 
of the manner in which they were addressed via the use of the templates and 
business rules summarised in sections 3 and 4 respectively, is provided in the 
Supporting Information. It should be noted that not all of these challenges are specific 
to ISA-TAB-Nano, i.e. some of them might be encountered when collecting data from 
the literature using other formats, and by no means are all of these challenges 
specific to collection of data from the published literature i.e. some of them might be 
encountered when trying to report primary experimental data according to the generic 
ISA-TAB-Nano specification. It should also be noted that not all of these challenges 
are necessarily within the scope of the generic ISA-TAB-Nano specification to resolve 
e.g. the definition of appropriate minimum information criteria. The need to address 
these challenges informed the design of the templates discussed in section 3 and the 
accompanying business rules, summarised in section 4 and presented in full in the 
Supporting Information, which were applied for the purpose of data collection from 
the nanotoxicology literature within the NanoPUZZLES EU project. It should be noted 
that no claim is made that all of these challenges are perfectly addressed via use of 
the resources presented in the current publication. The strengths and weaknesses of 
the manner in which these issues are addressed via the templates and business 
rules developed within NanoPUZZLES are discussed in the context of the detailed 
explanation of these challenges which is presented in the Supporting Information. In 
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addition, some of these challenges are returned to in the context of considering 
notable limitations of the resources developed within NanoPUZZLES. These notable 
limitations are summarised in section 7 and discussed in detail in the Supporting 
Information. 
 
Table 1: Summary of challenges with the generic ISA-TAB-Nano specification which 
were addressed in the current work 
Challenge 
no. 
Challenge Applicable, in 
principle, to any 
format rather 
than being 
specific to ISA-
TAB or ISA-
TAB-Nano? 
Applicable 
to ISA-
TAB? 
Applicable 
to ISA-TAB-
Nano? 
1 Standardised 
reporting of stepwise 
sample preparation 
needs to be 
established. 
X X X 
2 Ambiguity exists 
regarding where 
different kinds of 
information should be 
recorded. 
 X X 
3 Standardised X X X 
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recording of 
imprecisely reported 
experimental 
variables and 
measurements is 
required. 
4 Ambiguity exists 
regarding the 
creation of 
“Comment […]” 
fields. 
 X X 
5 Statistical terms need 
to be clearly defined. 
 Xa Xa 
6 Ambiguity exists 
regarding how to link 
to terms from 
ontologies. 
  X 
7 Ambiguity exists 
regarding whether or 
not “Parameter 
Value” or “Factor 
Value” column 
entries must be 
constant or not 
constant 
 X X 
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respectively. 
8 Linking to images 
reported in 
publications is 
challenging. 
X X X 
9 Standardised 
reporting of multiple 
component  
“characteristics”, 
“factors”, and 
“parameters” (e.g. 
mixtures) needs to 
be established. 
 X X 
10 A standardised 
means of linking 
multiple “external” 
files to a given 
Material file is 
required. 
  X 
11 Greater clarity 
regarding the 
existence of “unused” 
factors, parameters 
and measurement 
names in the 
 Xa X 
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Investigation file is 
required. 
12 A standardised 
approach for dealing 
with “non-applicable” 
metadata is required. 
X X X 
13 The concept of an 
“Investigation” should 
be more tightly 
defined for the 
purpose of collecting 
data from the 
literature. 
 X X 
14 Clearly defined 
minimum information 
criteria are required. 
X X X 
aIt should be noted that ISA-TAB is not designed to record experimental 
measurements in Assay files i.e. the “Measurement Value [statistic(measurement 
name)]” Assay file columns and the corresponding Investigation file “Study Assay 
Measurement Name” field are an ISA-TAB-Nano extension [17,37,39]. However, 
regarding the issue of clearly defining statistical terms (challenge no. 5), ISA-TAB 
datasets may include “external” data files (i.e. “external” to the basic Investigation, 
Study and Assay file types) such as “data matrix” files which may include statistical 
terms such as “p-value” [36,43]. Standardisation of statistical terms may be achieved 
via using terms from the STATistics Ontology (STATO) [44]. The challenge noted 
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here (challenge no. 5) regarding clearly defining statistical terms concerns how to 
appropriately create links to ontologies for these terms in ISA-TAB-Nano datasets. 
 
Section 3. NanoPUZZLES Data Collection Templates 
General Overview of Templates 
These templates were developed within the NanoPUZZLES project [33] and were 
specifically designed for collection of nanotoxicology data from the literature to 
support analysis of trends and the development of data driven computational models 
such as nano-QSARs. These templates are available from the myExperiment online 
repository [45,46]: file entry “NanoPUZZLES ISA-TAB-Nano Templates” [47]. Version 
2 of this file entry corresponds to the version of the templates referred to in the 
current publication and any corrections and/or extensions of these templates will also 
be made publicly available via future versions of this file entry. 
The motivation for employing non-generic templates, designed to record specific 
kinds of (meta)data of interest to specific researchers, as opposed to generic 
templates that merely indicate the kinds of fields which the four ISA-TAB-Nano file 
types (Investigation, Study, Assay, Material) can contain, is that specific files with 
specific fields would need to be created at the point of data collection in any case but 
creating these specific files “on-the-fly” (i.e. at the point of data collection) is 
problematic. For example, a generic Assay file template would only indicate that 
certain, unspecified, experimental variables and endpoint values should be recorded 
using “Parameter Value […]” (or other column type such as “Factor Value […]”) and 
“Measurement Value […]” columns respectively. However, when collecting certain 
kinds of data obtained with a given assay, a specific Assay file with specific 
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“Measurement Value […]” and “Parameter Value […]”columns (or other column types 
such as “Factor Value […]”) would need to be created to record the (meta)data of 
interest. Indeed, the Investigation file is designed to associate a given “Study Assay 
Measurement Type” (e.g. size) and “Study Assay Technology Type” (e.g. dynamic 
light scattering) with a given “Study Assay File Name”. Hence, specific templates 
(such as those developed in the current work) serve two important purposes: (a) they 
avoid the end user having to decide which specific fields, of a given type, should be 
created to record specific items of (meta)data; (b) they communicate to the end user 
which items of (meta)data should be reported in the dataset i.e. they effectively 
define minimum information criteria. However, in case the specific templates do not 
capture all the experimental (meta)data of interest to a given end user of the dataset, 
it is important to recognise that the templates may be updated with new fields (in 
existing templates) or additional specific templates may be created. 
The templates developed in the current work were adapted from generic Excel 
templates made available by the ISA-TAB-Nano developers [23]. The templates 
presented in this publication are designed to be compatible with version 1.2 of the 
ISA-TAB-Nano specification [23]. The generic templates were adapted as follows. 
(1) Predefined “Comment […]” fields were added to the Investigation file template 
for recording additional important metadata e.g. “Comment [GLP]” for 
recording whether or not the corresponding studies were carried out according 
to Good Laboratory Practice [27,48]. 
(2) Two specific Study file templates were created for sample preparation prior to 
physiochemical or cell based in vitro assays. (A Study file for sample 
preparation prior to in vivo assays was under development at the time of 
writing.) 
Page 20 
 
(3) Specific Assay file templates were created for (a) different kinds of 
physiochemical measurements and, in some cases, (b) for specific assays 
which might be employed to make those measurements. N.B. In some cases, 
where scenario (b) was not applicable, generic “Measurement Value 
[statistic(measurement name)]” columns were created with the statistic and/or 
measurement name presented as a generic “[TO DO: ….]” label: these labels 
should be replaced, as required, with specific statistic and measurement name 
values during data collection (as documented in the templates) or columns 
with these generic headings should be deleted if not applicable. For example, 
an Assay file template was designed for recording size measurements from a 
non-predetermined assay type (“a_InvID_PC_size_Method.xls”) in addition to 
some Assay file templates for recording size measurements obtained using 
specific assay types  - such as dynamic light scattering (DLS) 
(“a_InvID_PC_size_DLS.xls”) [41,42]. The former template 
(“a_InvID_PC_size_Method.xls”) includes the column “Measurement Value 
[[TO DO: appropriate average]([TO DO: appropriate size measurement])]”: this 
would be updated to “Measurement Value [mean of the number 
distribution(diameter)]”, to give but one possible example, during dataset 
creation. The latter template (“a_InvID_PC_size_DLS.xls”) includes the 
columns “Measurement Value [z-average (hydrodynamic diameter)]” and 
“Measurement Value [polydispersity index]”.  
(4) Specific Assay file templates were created for recording toxicity data for 
endpoints which were prioritised within the NanoPUZZLES project. 
(5) Predefined “Characteristics […]”, “Factor Value […]” and “Parameter Value 
[…]” columns were added to these Study and Assay file templates based upon 
consideration of which experimental variables were expected to affect the 
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associated assay measurements. For example, the Study template for cell 
based in vitro studies (“s_InvID_InVitro.CB.xls”) includes the predefined 
columns “Characteristics [cell type 
{EFO:http://www.ebi.ac.uk/efo/EFO_0000324}]” and “Factor Value [vehicle]”. 
(6) Predefined “Characteristics […]” columns were added to the Material file 
template for recording important chemical composition information, beyond 
that specified in the generic templates, along with nominal/vendor supplied 
values of various other physicochemical parameters: e.g. “Characteristics 
[Product impurities found 
{MEDDRA:http://purl.bioontology.org/ontology/MDR/10069178}]”, 
“Characteristics [Major crystalline phase]” and “Characteristics [average size]”.  
(7) Predefined “Comment […]” columns were added to the Material, Study and 
Assay file templates for recording key metadata that could (a) assist in 
interpreting the results or (b) allow the quality of the results to be assessed. 
For example, the template “a_InvID_PC_size_TEM.xls” for recording size by 
transmission electron microscopy (TEM) contains the columns “Comment 
[primary particle measurements]” and “Comment [size: from graph]” to address 
requirements of type (a) and (b) respectively. The “Comment [primary particle 
measurements]” column  was designed to report whether or not the size 
measurements obtained were explicitly stated, in the publication from which 
they were extracted, to have been made for the primary particles: in principle, 
TEM might be used to provide information about agglomerates, aggregates or 
primary (individual) particles for a given prepared sample [49,50]. The 
“Comment [size: from graph]” column was predicated on the assumption that 
data extracted from graphs (which is not uncommon when collecting data from 
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the literature) is less reliable (i.e. more prone to transcription errors) than data 
extracted from tables or text. 
(8) For some fields, drop-down lists with possible field entries were created using 
the “Data Validation” option in Excel 2010. 
(9) The fields were colour coded to indicate those fields which were judged to be 
essential (green), desirable (yellow) or not important for the purposes of the 
NanoPUZZLES project (red).  
(10) Some fields (e.g. the Material file “Material Design Rationale” column) which 
were not considered important for the purposes of the NanoPUZZLES project 
were simply deleted. 
(11) Detailed comments were added (via the Excel 2010 “Review” tab) describing 
how different predefined fields should be populated during data collection.  
(12) The fields in the Investigation template (“i_InvID.xls”) were populated insofar 
as possible prior to data collection. This included specifying predefined 
“factors” and “parameters” (c.f. other templates) and defining a set of 
ontologies from which terms should (preferentially) be obtained during data 
collection. 
(13) Some of the fields in the Study, Assay and Material template were populated 
with indicated values where appropriate. In some cases, these indications 
might actually be literally entered as values for the corresponding field entries 
e.g. “size determination by DLS” entered in the first row of the “Protocol REF” 
column in the “a_InvID_PC_size_DLS.xls” template. However, in other cases, 
the suggested entries should not be entered literally e.g. “size determination 
by <Assay technology type>” entered in the first row of the “Protocol REF” 
column in the “a_InvID_PC_size_Method.xls” template, where “<Assay 
technology type>” would be replaced with the name of the relevant method, 
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such as “environmental scanning electron microscopy” [51,52] for the Assay 
file (“a_TOY.article_PC_size_ESEM.xls”) in the “Toy Dataset” (see section 6) 
derived from the  “a_InvID_PC_size_Method.xls” template. 
(14) NanoPUZZLES specific naming conventions were established (as 
suggestions, rather than business rules) for creating files based on these 
templates. For example, “InvID” denotes “Investigation Identifier” and “Method” 
denotes an assay measurement technique such as dynamic light scattering 
(DLS). 
(15) A new “ImageLink” template (“ImageLink_NUMBER_for_InvID.xls”) was 
created for linking to images reported in publications which are not associated 
with a single file that can be redistributed as part of a dataset or uniform 
resource identifier (URI). The use of this template is defined by 
NanoPUZZLES business rule no. 18 (see section 4 and Supporting 
Information Section B). 
 
Identification of Important Experimental Variables and Characterisation Data 
The experimental variables (for both toxicological and physicochemical assays) and 
types of physicochemical characterisation data which the templates were designed to 
capture were based upon considering the well-known MINChar Initiative Parameters 
List [53], the provisional recommendations developed within the NanoSafety Cluster 
Databases Working Group [26], other  resources developed within the context of the 
NanoSafety Cluster projects PreNanoTox [54,54] and MARINA [55] as well as 
discussions with nanotoxicology researchers and consideration of the published 
literature regarding toxicologically significant physicochemical characterisation 
parameters (for nanomaterials) and experimental variables which could significantly 
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affect toxicological or physicochemical measurements [10,12,49,56–61]. However, no 
claim is made that the templates developed to date within the NanoPUZZLES project 
would capture all of the experimental variables or relevant characterisation 
information indicated by the cited proposals or otherwise recognised as important in 
the nanotoxicology community.  
Physicochemical Characterisation Data Captured by the Templates 
The categories of physicochemical information these templates were designed to 
capture, along with the corresponding Material and/or Assay file templates, are 
summarised in Table 2. In keeping with the generic ISA-TAB-Nano specification 
(version 1.2) [62], information which could be recorded using an Assay file template 
(“a_.....xls”) should only be recorded using the Material file template 
(“m_MaterialSourceName.xls”) if its value was nominal or vendor supplied.  
These categories of physicochemical information  correspond to all of the kinds of 
physicochemical information highlighted as being important in the MINChar Initiative 
Parameters List [53], with the context dependence stressed by this initiative being 
(partially) captured via recording sample conditions using “Factor Value […]” columns 
in the physicochemical Study file template (“s_InvID_PC.xls”) e.g. “Factor Value 
[medium]”.  
In order to construct these templates, careful consideration was required of exactly 
how to record different kinds of physicochemical information highlighted as being 
important. Firstly, this required consideration of which measurements might 
correspond to different kinds of physicochemical information; the “minimum” 
characterisation parameters reported in various proposals [12,53] are sometimes 
quite broadly defined e.g. “Surface Chemistry, including reactivity, hydrophobicity” 
[53]. Secondly, this required consideration of which corresponding Material file 
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“Characteristics […]” and/or Assay file “Measurement Value […]” columns needed to 
be defined  - as well as, in some cases, which “Parameter Value […]” columns 
needed to be defined e.g. “Parameter Value [analyte role]” (i.e. the dissolved species 
being measured) for dissolution Assay file templates. No claim is made that the 
templates developed to date within the NanoPUZZLES project would capture all 
relevant measurements which might be associated with a given category of 
physicochemical information listed in Table 2.  
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Table 2: Categories of physicochemical information which the NanoPUZZLES ISA-TAB-Nano templates were designed to capture  
Category Template(s) Comments 
chemical composition 
(including surface 
composition, purity and 
levels of impurities) 
“m_MaterialSourceName.xls” Only chemical composition information associated with the 
original / vendor supplied nanomaterial should be reported 
here i.e. not adsorption data (see below).  
crystal structure / 
crystallinity 
“m_MaterialSourceName.xls”; 
“a_InvID_PC_crystallinity_Method.xls” 
 
shape “m_MaterialSourceName.xls”; 
“a_InvID_PC_shape_Method.xls” 
Both qualitative descriptions of shape or “aspect ratio” data 
[60] can be recorded.  
particle size / size 
distribution 
“m_MaterialSourceName.xls”; 
“a_InvID_PC_size_Method.xls”; 
“a_InvID_PC_size_DLS.xls”; 
“a_InvID_PC_size_TEM.xls” 
Dynamic light scattering (DLS) [41] or transmission electron 
microscopy (TEM) [63,64] measurements are captured using 
the indicated Assay file templates. Otherwise, unless size 
values are nominal/vendor supplied, size measurements are 
captured via the generic Assay file template. 
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surface area “m_MaterialSourceName.xls”; 
“a_InvID_PC_surface area_Method.xls” 
This was designed to record “specific surface area” values  
i.e. surface area per unit mass [58]. 
surface charge/ zeta 
potential 
“m_MaterialSourceName.xls”; 
“a_InvID_PC_zetapotential_Method.xls” 
Zeta potential is commonly used as a proxy for surface 
charge [58]. 
adsorption “a_InvID_PC_adsorption_Method.xls” This was designed to record “adsorption constants” [57] and 
(equilibrium) adsorption percentages [65] for specific small 
molecule / macromolecular “probe” species. 
reactivity “a_InvID_PC_reactivity.rateofchange_of
.X_SeparationTechnique_Method.xls” 
The design of this template reflects the fact that, for some 
reactivity assays, the analysed species needs to be removed 
prior to making measurements [66].  
dissolution (1) “a_InvID_PC_dissolution.conc_of
.X_SeparationTechnique_Method
.xls” ;  
(2) “a_InvID_PC_dissolution.fraction-
dissolved_SeparationTechnique_
Method.xls”; 
The design of these templates reflects the fact that a number 
of different kinds of dissolution measurement may be made 
for inorganic nanoparticles: (1) the (time dependent) 
concentrations of various species released by dissolution 
[65,67] (which may be a redox process [67]); (2) the (time 
dependent) percentage of original nanoparticles dissolved 
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(3) “a_InvID_PC_dissolution.rate_of.
X_SeparationTechnique_Method.
xls” 
[68]; (3) the (time dependent) dissolution rate [69]. The design 
of these templates further reflects the fact that dissolution 
assay protocols typically employ a separation step to isolate 
the analysed species [61]. 
molecular solubility “a_InvID_PC_solubility_Method.xls” In the current context, the Chemical Methods Ontology 
definition of “solubility” [70] was used: “the concentration of a 
solute in a saturated solution”. This Assay template was 
specifically designed for recording molecular “solubility” 
measurements  e.g. the solubility of fullerene nanoparticles 
[71]. 
agglomeration / 
aggregation 
“a_InvID_PC_AAN_BETapproach.xls” This template was designed for recording the “average 
agglomeration number” derived from BET gas adsorption 
data, size measurements and particle density values [58,72]. 
However, it should be noted that context recording of size 
information (using the Assay file templates noted above) also 
conveys information about the agglomeration state [58]. In 
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addition, a number of physicochemical Assay files (e.g. 
“a_InvID_PC_size_Method.xls”) contain “Comment […]”  
columns (e.g. “Comment[primary particle measurements]”) 
designed to record whether or not the reported data are noted 
to refer to the primary particles (as opposed to agglomerates 
and/or aggregates) by the authors of the reference from 
which the data were extracted. 
hydrophobicity “m_MaterialSourceName.xls”; 
“a_InvID_PC_logP_Method.xls” 
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Experimental Variables Captured by the Templates 
The experimental variables associated with sample preparation prior to applying 
assay protocols for (1) physicochemical measurements (see above) or (2) cell based 
in vitro toxicological assays are principally described via “Factor Value […]” columns 
in two Study file templates: (1) “s_InvID_PC.xls”, (2) “s_InvID_InVitro.CB.xls”.  
For physicochemical studies, these “Factor Value […]” columns record the values of 
experimental variables associated with the preparation of a nanomaterial sample 
prior to application of an assay protocol e.g. “Factor Value [physical state]” (for 
recording whether or not the sample was prepared as a suspension or a powder), 
“Factor Value [medium]” (for recording the suspension medium i.e. not applicable if 
the “physical state” is a powder), “Factor Value [Sonication]” (for recording whether or 
not the sample was sonicated [49]).  
For cell based in vitro studies, these “Factor Value […]” columns record the values of 
experimental variables associated with preparation of the composite sample being 
tested i.e. the nanomaterial suspension and the biological component on which the 
effect of the nanomaterial will be evaluated. Hence, they are designed to capture 
different kinds of experimental variables: (1) those which are relevant to preparation 
of the biological sample prior to adding the nanomaterial e.g. the “Factor Value 
[culture medium glucose supplement]” in  “s_InvID_InVitro.CB.xls” designed to record 
whether or not the cells were grown in glucose containing “culture medium”, which 
may significantly affect the observed toxicity in some in vitro assays [56]; (2) those 
which are relevant to the preparation of the nanomaterial sample applied to the 
biological sample e.g. “Factor Value [vehicle]” and “Factor Value [Sonication]” for 
capturing the exposure medium for an in vitro assay (e.g. “Ham's F-12 medium” [49]) 
and whether or not sonication was applied to the tested nanomaterial suspension 
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respectively; (3) those which are relevant to the combined sample to which the assay 
protocol is applied e.g. “Factor Value [cells Exposure Duration]”. 
Capturing of the experimental conditions under which corresponding physicochemical 
characterisation and toxicity data were generated is important to assess whether or 
not characterisation was performed under biologically relevant conditions [73]. For 
example, whether or not a given size and toxicity measurement, for the same 
nanomaterial, were performed in the same suspension medium could be determined 
via comparing the corresponding “Factor Value [medium]” and “Factor Value 
[vehicle]” entries in the physicochemical and in vitro Study files respectively. 
In addition, for the “s_InvID_InVitro.CB.xls” Study file template, “Characteristics […]” 
columns associated with the “Source Name” column (i.e. positioned after the “Source 
Name” column but before the “Sample Name” column) are used to describe 
experimental variables which are inherent to the biological specimen: "cell type”, “cell 
line”, “organism” and “strain”, as defined in the Experimental Factor Ontology (EFO) 
[74,75].  
Experimental variables specifically associated with assay protocols are recorded in 
Assay files, principally using “Parameter Value […]” columns e.g. “Parameter Value 
[Instrument]”, “Parameter Value [negative control]”. 
It should be noted that the manner in which some of these experimental variables are 
captured via these templates might be carried out differently by other researchers 
and may deviate from the expectations of the generic ISA-TAB(-Nano) specification 
[17,23,36].  Some of the “Factor Value […]” columns (e.g. “Factor Value [physical 
state]” or “Factor Value [final cell density]” in “s_InvID_PC.xls” and  
“s_InvID_InVitro.CB.xls” respectively) might be considered to refer to characteristics 
of the prepared sample. Hence, these kinds of variables might elsewhere be 
recorded using “Characteristics […]” columns associated with the “Sample Name” 
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column i.e. positioned after the “Sample Name” column [36]. Other variables 
recorded via “Factor Value […]” columns (e.g. “Factor Value [Sonication Duration]”) 
might be kept constant in some experiments [76], hence could be considered 
protocol parameters which would be recorded using “Parameter Value […]” columns 
[17]. However, the use of “Factor Value […]” columns to record these latter variables 
was deemed appropriate to account for scenarios in which these variables (e.g 
sonication duration) were varied to assess their effect on assay measurements [49]. 
The fact that certain kinds of variables might be considered, in keeping with the 
generic ISA-TAB-Nano specification [17] discussed in section 1, “parameters” in one 
set of experiments and “factors” in another depending upon whether or not they were 
kept constant or varied to study their effects on the assay measurement values does 
not lend itself to consistently organising these experimental variables in predefined 
template columns as developed in the current work.  
The potential ambiguity associated with how to record different experimental 
variables can be illustrated by considering differences between the NanoPUZZLES 
ISA-TAB-Nano [47] and ToxBank ISA-TAB templates [77,78]: (1) the NanoPUZZLES 
Study file template  “s_InvID_InVitro.CB.xls” contains the column“Factor Value 
[vehicle]”, whereas the ToxBank Study file template “studySample.xml” contains the 
column "Characteristics[vehicle]"; (2) the NanoPUZZLES Assay file templates treat 
the identity of assay controls as “Parameter Value […]” entries (e.g. “Parameter 
Value [negative control]”), whereas the ToxBank Study file template uses a 
“Characteristics […]” column ("Characteristics[control]") to assign negative or positive 
control status to different samples. 
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Toxicity Data Captured by the Templates 
Assay file templates were developed to capture toxicity data associated with two 
toxicological endpoints which were initially prioritised within the NanoPUZZLES 
project: cytotoxicity (“a_InvID_cytotoxicity.cell-viability_Method.xls”, 
“a_InvID_cytotoxicity.sub-lethal_Method.xls”) and genotoxicity 
(“a_InvID_genotoxicity_Method.xls”). Cytotoxicity and genotoxicity are amongst the 
endpoints which are frequently considered when evaluating metal oxide 
nanoparticles in cell based in vitro assays [4,79]. A number of nano-QSAR models 
have been developed for cytotoxicity [13,80–86] and some models have also been 
developed for nanomaterial genotoxicity [9,87,88].  
The genotoxicity Assay file template (“a_InvID_genotoxicity_Method.xls”) was 
designed to capture the most important outputs from different kinds of genotoxicity 
tests. Specifically, the “Parameter Value [Biomarker]” was designed to record the, 
test specific, biomarker whose increase relative to control values (“Measurement 
Value [mean(increase in biomarker level)]”) would be determined for nanomaterial 
exposed samples. For example, “Parameter Value [Biomarker]” might report 
“micronuclei” or “number of revertants” if the method employed was the micronucleus 
test [89] or Ames test [90,91] respectively. 
Since the results obtained for different sample preparation conditions (e.g. different 
tested concentrations) are usually used to derive an overall genotoxicity study call 
(i.e. “positive”, “negative” or “equivocal”) [89,91], a corresponding  “Measurement 
Value [study call]” was added. N.B. Values in this latter column should be associated 
with “derived sample” identifiers as introduced in NanoPUZZLES business rule no. 10 
(see section 4 and Supporting Information Section B for an in-depth explanation). 
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The lethal cytotoxicity Assay file template (“a_InvID_cytotoxicity.cell-
viability_Method.xls”) was designed to record data corresponding to a reduction in 
cell “viability” (typically interpreted as an increase in “cell death”) obtained from cell 
based in vitro assays such as MTT, MTS, LDH, and colony forming unit (CFU) 
counting [92–94]. The “percent cytotoxicity” columns (“Measurement Value 
[mean(percent cytotoxicity)]”, “Measurement Value [standard deviation(percent 
cytotoxicity)]”) are designed to record the “percent cytotoxicity” (a measure of cell 
death relative to controls equal to 100 – “percent viability”) [95] associated with 
specific sample preparations i.e. a specific value for the administered concentration 
or dose [96]. Other “Measurement Value […]” columns were designed to record 
measures of cytotoxicity derived from dose (or concentration) response relationships: 
the lowest observed effect level (LOEL) [97] (used, in the current work, to denote the 
lowest concentration/dose at which significant cell death relative to controls is 
observed), the LC50 [98] and LD50 [99] i.e. the concentration and dose respectively 
which, in the current context, kills 50% of the treated cells relative to controls. N.B. 
Values in these latter columns should be associated with “derived sample” identifiers 
as introduced in NanoPUZZLES business rule no. 10 (see section 4 and Supporting 
Information Section B for an in-depth explanation). 
The sub-lethal cytotoxocity Assay file template (“a_InvID_cytotoxicity.sub-
lethal_Method.xls”) was designed to record data from cell based in vitro assays 
designed to detect sub-lethal phenomena which might be quantified in terms of 
changes in key biomarkers. For example, oxidative stress and inflammation might be 
detected via measuring the level of glutathione or various cytokine biomarkers 
respectively [92]. (These sub-lethal phenomena would not be considered 
“cytotoxicity” by all researchers [79].) The manner in which this template was 
designed to capture sub-lethal cytotoxicity data is similar to the design of the 
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genotoxicity Assay file template discussed above: the “Parameter Value [Biomarker]” 
column entries would state, for example, “glutathione” (depending upon the assay), 
with “Measurement Value […]” columns recording the “increase in biomarker level” 
(relative to control) as well as the LOEL [97] if this is reported. N.B. Values in this 
latter column should be associated with “derived sample” identifiers as introduced in 
NanoPUZZLES business rule no. 10 (see section 4 and Supporting Information 
Section B for an in-depth explanation). 
Section 4. NanoPUZZLES Business Rules 
Within the NanoPUZZLES project [33], a number of project specific business rules 
were created for the purpose of specifying how the ISA-TAB-Nano templates 
described in section 3 should be populated with data from literature sources. As 
noted in section 2, and fully explained in the Supporting Information, some of these 
business rules were specifically designed to address challenges associated with the 
generic ISA-TAB-Nano specification. A summary of these business rules is provided 
in Table 3. The Supporting Information presents detailed explanations of how these 
business rules should be applied and, where appropriate, considers their strengths 
and weaknesses compared to possible alternatives which might be applied in future 
work. 
These new rules were applied in addition to the rules which are part of the generic 
ISA-TAB-Nano specification as of version 1.2 [17,23,36–40]. (The new rules took 
precedence over the generic specification in case of conflicts.) It should also be 
remembered that additional guidance on creating ISA-TAB-Nano datasets using 
these templates is provided in section 3 and that guidance on populating individual 
fields is provided in the Excel-created comments linked to specific column titles. 
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Finally, in keeping with the generic specification, the Investigation file and all 
corresponding files (Study, Assay and Material files along with all external files when 
applicable), for a single dataset, were added to a single, flat compressed ZIP archive 
(see section 5). 
 
Table 3: Summary of the NanoPUZZLES business rules 
Business 
rule no. 
Short description 
1 A new “Investigation” (corresponding to a new dataset comprising a 
single Investigation file, a set of Study, Assay and Material files and any 
“external” files if applicable) should be created for each reference (e.g. 
journal article), unless that reference specifically states that additional 
information regarding experiments on the same original nanomaterial 
samples was reported in another reference. 
2 The “Factor Value […]” columns in the Study file refer to those values 
which are applicable to the sample prepared immediately prior to 
application of an assay protocol. 
3 If the entry for a “Characteristics […]”, “Factor Value […]” or “Parameter 
Value […]” column corresponds to multiple components (e.g. mixtures), 
record this as a semi-colon (“;”) delimited list of the separate 
components. 
4 If the entry for a “Characteristics […]”, “Factor Value […]” or “Parameter 
Value […]” column corresponds to multiple components, record the 
entries in corresponding columns as a semi-colon (“;”) delimited list with 
the entries in the corresponding order. 
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5 Any intrinsic chemical composition information associated with a 
nanomaterial sample (as originally sourced) should be recorded using a 
Material file even if it is determined/confirmed using assay 
measurements reported in the publication from which the data were 
extracted. 
6 Any suspension medium associated with the nanomaterial sample (as 
originally sourced) should only be described using a Material file 
“Material Description” column. 
7 Any impurities should be described using entries in the relevant 
Material file “Characteristics [….]” columns. 
8 Any original nanomaterial components, which are neither a suspension 
medium nor described as “impurities” in the reference from which the 
data are extracted, should be described using separate rows of the 
Material file as per the generic ISA-TAB-Nano specification. 
9 All “Sample Name” values for “true samples” should have the following 
form: “s_[Study Identifier]_[x]” e.g. “s_[Study Identifier]_1”a 
10 Assay file “Measurement Value […]” column entries which correspond 
to concentration-response curve statistics, or similarly derived 
measures, should be associated with a “derived sample” identifier 
rather than a “true sample” identifier. 
11 Imprecisely reported experimental variables should be reported using 
“Factor Value [statistic(original factor name)]” columns created “on-the-
fly”. 
12 Imprecisely reported measurement values should be reported using 
“Measurement Value [statistic(measurement name)]” columns created 
Page 38 
 
“on-the-fly”. 
13 “Comment […]” columns (rows) can be added without restriction to a 
Study, Assay, Material (Investigation) file as long as they are 
appropriately positioned and as long as each new “Comment […]” 
column (row) has a unique name for a given file. 
14 All “statistic” names must be entered in the corresponding Investigation 
file template “Comment [Statistic name]” row. 
15 When linking to terms from ontologies, the “preferred name” should be 
selected and the full ID entered in the corresponding “Term Accession 
Number” field. 
16  “Factor Value […]” column entries are allowed to be constant. 
17 Only “Parameter Value […]” column entries associated with a given 
“Protocol REF” column entry in a Study or Assay file need to be 
constant. 
18 Images should be linked to assay measurements using a new 
“ImageLink” file type, if the generic ISA-TAB-Nano approach cannot be 
applied. 
19 Any nanomaterial structure representation files, which are not 
associated with specific Assay file  “Measurement Value […]” entries, 
should be linked to the corresponding Material file using ZIP archives 
specified in the appropriate “Material Data File” column entry. 
20 Empty “Factor Value […]”, “Parameter Value […]” or “Measurement 
Value […]” columns in Study or Assay files can be deleted without 
having to update the corresponding Investigation file “Study Protocol 
Parameters Name”, “Study Factor Name”, or “Study Assay 
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Measurement Name” fields. 
21 Non-applicable columns should be populated with “N/A” where this 
conveys information. 
22  “Measurement Value [statistic(measurement name)]” columns in the 
templates which use a label of the form “[TO DO:…]” for the statistic or 
measurement name must either be updated, based on the kind of 
statistic and/or measurement name indicated by the label(s), or deleted. 
a Here, the “[Study Identifier]” [37] is unique to the corresponding Study file and “[x]” 
denotes a numeric value which is specific to a given “true sample”, meaning a 
prepared sample corresponding to a specific set of experimental conditions, in 
contrast to the “derived sample” concept introduced in NanoPUZZLES business rule 
no. 10. 
 
Section 5. NanoPUZZLES Python Program to Facilitate 
Computational Analysis and Database Submission 
Excel-based ISA-TAB-Nano templates are presented in this publication and 
elsewhere [17,23]. However, ISA-TAB-Nano files (Investigation, Study, Assay, 
Material) are commonly implemented in tab-delimited text format [100], reflecting the 
fact that ISA-TAB-Nano is an extension of ISA-TAB and ISA-TAB is intended to be 
implemented using tab-delimited text files (Investigation, Study, Assay) [36]. Indeed, 
the authors of the current publication are unaware of any software specifically 
designed for parsing ISA-TAB datasets [22,77,101], which might be extended to 
parse ISA-TAB-Nano datasets, or software specifically designed for parsing ISA-
TAB-Nano datasets [102,103], which does not require the key file types 
(Investigation, Study, Assay and, for ISA-TAB-Nano, Material) to be represented in 
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tab-delimited text format. This includes publicly available, online resources recently 
developed within the context of the MODERN project [102]: an ISA-TAB-Nano 
dataset validator and “Nanomaterial Data Management System” (“nanoDMS”) – with 
the latter program implementing a web-based, searchable database system which is 
able to, amongst other functionality, import validated ISA-TAB-Nano datasets 
[30,104,105]. 
Hence, to facilitate database submission and other computational analysis, a Python 
[106] program was written, within the context of the NanoPUZZLES project, to enable 
automated conversion of an ISA-TAB-Nano dataset prepared using Excel-based 
templates to a tab-delimited text version of this dataset. Specifically, this program 
was designed to take a flat, compressed ZIP archive (e.g. “Investigation 
Identifier.zip”) containing Excel (“xls”) versions of an Investigation file, plus 
corresponding Study, Assay and Material files, and convert this to a flat, compressed 
ZIP archive (e.g. “Investigation Identifier-txt.zip”) containing tab-delimited text 
versions of these files. N.B. Any external Excel-based “xls” files (e.g. “ImageLink” 
files introduced in the current work) contained in the archive will also be converted to 
tab-delimited text files and other external files will be transferred to the new archive 
without modification. 
The program has four Open Source dependencies: a Python interpreter [106] along 
with the xlrd, xlwt [107] and unicodecsv [108] Python modules. Specifically, for the 
purposes of code development, Python version 2.7.3, xlrd version 0.93, xlwt version 
0.7.5 and unicodecsv version 0.9.4 were employed. All code was tested on a platform 
running Windows 7. The program does not have a graphical user interface (GUI): 
input is specified from the command prompt e.g. “python xls2txtISA.NANO.archive.py 
–i InvestigationID.zip”.  The source code and documentation are available via the 
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“xls2txtISA.NANO.archive” project on GitHub [109]. Version 1.1 of the program is 
referred to in the current publication [110]. 
Figure 2 provides an overview of the program’s functionality. As part of converting 
from Excel-based to tab-delimited text versions of ISA-TAB-Nano files, this program 
carries out basic checks on the datasets (e.g. checking for the presence of at least 
one file of type Investigation, Study, Assay, Material) and attempts to correct for basic 
potential errors in the file contents  (e.g. removing  line endings inside field entries) 
which might be introduced when manually preparing ISA-TAB-Nano files using Excel 
templates. However, the program does not carry out any sophisticated “parsing” of 
the datasets i.e. no attempt is made to interpret the data in terms of the meaning of 
individual fields or the contents of individual field entries. No checks are carried out 
on the consistency of different files. Issues such as case sensitivity, null values and 
special characters (beyond removing internal line endings) are not addressed. 
Nontheless, by facilitating conversion to tab-delimited text format, this enables the 
datasets to be parsed via more sophisticated tools such as those developed for 
validating ISA-TAB-Nano datasets within the MODERN project [102,103]. 
As well as the default behaviour of this program described above, two command line 
options were specifically introduced to enable submission of an ISA-TAB-Nano 
dataset developed using these Excel templates to a database developed using the 
nanoDMS software [30,102,104,105]. The first option (“-a”) truncates all ontology 
identifiers: at the time of writing, “.” characters were not permitted by the nanoDMS 
system in the headers of the Material, Study or Assay files i.e. the column heading 
“Characteristics [shape {NPO:http://purl.bioontology.org/ontology/npo#NPO_274}]” in 
the Material files generated using the default options would need to be converted to 
“Characteristics [shape {NPO:NPO_274}]” etc. The second option (“-c”) removes all 
“Comment […]” rows from the Investigation file: at the time of writing, these rows 
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would also (indirectly) trigger errors when trying to load ISA-TAB-Nano datasets into 
the nanoDMS system. N.B. The output files are automatically named according to the 
options selected. 
 
Figure 2: Schematic overview of the steps carried out by the Python program for 
converting Excel (“xls”) based ISA-TAB-Nano datasets to tab-delimited text (“txt”) 
based ISA-TAB-Nano datasets. For simplicity, only one Investigation, Study, Assay 
and Material file (and no external file such as an image) is included in this 
hypothetical dataset. N.B. In addition to the file processing steps summarised in this 
schematic, basic checks are carried out on the input: (1) there should be at least one 
Investigation, Study, Assay and Material file; (2) there should be no duplicate column 
titles in a Study, Assay or Material file other than those which are explicitly allowed by 
the ISA-TAB-Nano specification (e.g. “Unit”). 
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Section 6. Toy Dataset 
In order to illustrate the use of all of the NanoPUZZLES template files, a “Toy 
Dataset” was created based upon these template files in accordance with the 
business rules summarised in section 4 and discussed in detail in the Supporting 
Information. It must be noted that the (meta)data contained within this “Toy Dataset” 
are not real, although they are based upon consideration of the nanoscience 
literature [4,49,51,57,58,60,61,65,66,68,69,71,72,74,92,111,112]. Indeed, no primary 
literature reports presenting data corresponding to all of the templates were identified 
as of the time of writing. An overview of the toy data content of this “Toy Dataset”, 
generated after uploading this dataset into the nanoDMS database [105], is provided 
in the following figures: Figure 5 and Figure 6. 
This “Toy Dataset” is available from the Supporting Information in three versions: (1) 
“TOY.article.resub.zip” corresponds to a flat archive containing files created using the 
original Excel templates and saved as “xls” files; (2) “TOY.article.resub-txt.zip” is the 
version of this dataset created using the default options of the Python program 
described in section 5; (3) “TOY.article.resub-txt_opt-a_opt-c.zip” was generated 
using the “-a” and “-c” flags of this software. This latter version (“TOY.article.resub-
txt_opt-a_opt-c.zip”) could be uploaded into the nanoDMS database [105], which is 
further discussed in section 7. The following figures provide an overview of the 
upload procedure for this dataset as well as illustrating the use of the nanoDMS 
system for retrieving these data: Figure 3, Figure 4, Figure 5, Figure 6, Figure 7. 
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Figure 3: Upload options for loading the suitable version of the “Toy Dataset” 
(“TOY.article.resub-txt_opt-a_opt-c.zip”) into the nanoDMS online database, which 
can be accessed via the cited web-address [105]: ontology identifiers were truncated 
and Investigation “Comment […]” rows deleted, using the Python program described 
in section 5, in order to enable this submission. N.B. Since these were not real data, 
the upload settings were selected such that the “Toy Dataset” was not publicly visible 
after uploading. 
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Figure 4: Confirmation that the “Toy Dataset” ("TOY.article.resub-txt_opt-a_opt-
c.zip") was successfully uploaded: no error messages were generated by the internal 
ISA-TAB-Nano dataset validator and the warning messages regarding the position of 
the "Measurement Value [...]" and "Image File" columns reflect the addition of the 
“Measurement Value […]” column type to ISA-TAB-Nano, as compared to ISA-TAB, 
Assay files. 
 
Figure 5: A summary of the in vitro cell-based assay toy data in the “Toy Dataset” 
("TOY.article.resub-txt_opt-a_opt-c.zip") generated via the nanoDMS system. This 
summary can be generated via selecting the applicable dataset entry under the 
"Browse" menu of the nanoDMS system. 
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Figure 6: A summary of the physicochemical assay toy data recorded in the “Toy 
Dataset” ("TOY.article.resub-txt_opt-a_opt-c.zip"), generated via the nanoDMS 
system as per Figure 5. N.B. This does not include the hypothetical chemical 
composition and nominal/vendor supplied data recorded in the Material files. 
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Figure 7: Retrieving the “Toy Dataset” ("TOY.article.resub-txt_opt-a_opt-c.zip") via 
searching for "Oxidative Stress" data in the nanoDMS system. N.B. At the time of 
writing, this search functionality was not case insensitive. 
 
Section 7. Critical Appraisal of the Current Work and Possible 
Future Directions 
Some Notable Limitations of the NanoPUZZLES Templates and Business Rules 
Introduced in this Article 
The strengths and weaknesses of the manner in which the challenges associated 
with the generic ISA-TAB-Nano specification (see section 2) were addressed via the 
templates and business rules developed within NanoPUZZLES are discussed in 
Supporting Information Section A. Beyond the need to address these general 
challenges, the specific strengths and weaknesses related to the design of the 
NanoPUZZLES templates (section 3) and business rules (section 4) were also 
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discussed in section 3 and Supporting Information Section B respectively. For 
example, it was noted in section 3 (under the “Experimental Variables Captured by 
the Templates” sub-section) that the manner in which certain experimental variables 
are recorded using the NanoPUZZLES templates may deviate from how other 
researchers would capture these metadata using ISA-TAB-Nano. Likewise, a 
possible alternative to the use of “derived sample” identifers (introduced in 
NanoPUZZLES business rule no. 10) for capturing concentration-response curve 
statistics, such as an LC50 [98], and related data is presented when discussing this 
business rule in Supporting Information Section B. 
Table 4 summarises what are arguably the most notable remaining challenges 
associated with using these resources (templates and business rules) to collect 
nanotoxicology data from the literature. An in-depth discussion of these challenges, 
along with some suggestions for addressing them, is provided in Supporting 
Information Section C. 
  
Table 4: Summary of some notable limitations of the NanoPUZZLES templates and 
business rules 
Limitation 
no. 
Brief description 
1 Standardised reporting of stepwise sample preparation is still not handled 
perfectly. 
2 Time dependent physicochemical characterisation data may not be perfectly 
captured by the templates. 
3 Recording of reaction rate constants and quantum yields may need revision. 
4 The manner in which chemical composition information is captured via the 
templates may require revision. 
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5 There is the possibility of information loss when mapping (raw) data reported 
in the literature onto predefined “Measurement Value […]” columns. 
6 The current templates are not best suited to capturing experimental data for 
all kinds of samples. 
7 The business rules regarding multiple component “characteristics”, “factors” 
or “parameters” (e.g. mixtures) may require revision. 
8 The templates are not currently designed to capture data from in vivo 
toxicology studies. 
9 Manually populating the Excel templates is time consuming and error prone. 
 
Integrating Data Collected using the NanoPUZZLES Templates and Business 
Rules into Databases 
Various options currently exist, or are under development, for submitting the ISA-
TAB-Nano files generated using the resources presented in sections 3, 4 and (if 
relevant) 5 to online, searchable databases. Submission to these databases should 
assist nano-QSAR researchers in identifying and retrieving data for modelling. 
One option, as discussed previously, would be to submit the files to a database 
developed using the freely available “Nanomaterial Data Management System” 
(“nanoDMS”) software [30,102–105] which was created within the context of the 
MODERN project. This database system was specifically designed to act as a 
searchable, online repository for ISA-TAB-Nano files and upload to the system is only 
allowed if the internal ISA-TAB-Nano dataset validator, also available as a 
standalone online tool [102], does not generate any error messages. An existing 
implementation of such a database was publicly available at the time of writing [105] 
and submission of a suitably prepared version of the “Toy Dataset” described in 
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section 6 was successful (see Figure 3, Figure 4, Figure 5, Figure 6, Figure 7). 
However, as discussed in section 5 and section 6, this submission would currently 
require some modification of the datasets i.e some ontology identifers would need to 
be truncated and Investigation file “Comment […]” rows would need to be removed. 
Another possible option would be to upload datasets generated using these 
resources into the eNanoMapper database [31,113,114]. This might be achieved via 
using the eNanoMapper customisable Excel spreadsheet parser to extract data from 
the Excel files created directly using the NanoPUZZLES templates [115]. 
Alternatively, it might be possible for an ISA-TAB-Nano parser (under development 
within eNanoMapper at the time of writing) to parse the tab-delimited text files 
generated using the program described in section 5. In either case the mapping of 
the input files onto the internal eNanoMapper data model would be performed in a 
transparent way, either explicitly via a JSON configuration file or implicitly by the ISA-
TAB-Nano parser [31]. 
A brief illustration of some of the functionality of the nanoDMS database and its use 
for querying data generated using the NanoPUZZLES templates and business rules 
is presented in section 6: Figure 3, Figure 4, Figure 5, Figure 6, Figure 7. However, it 
should be noted that an in-depth discussion of the complete functionality of the 
nanoDMS and eNanoMapper databases is beyond the scope of the current paper. 
Interested readers are referred to the cited references for further details regarding the 
nanoDMS [30,104,105] and eNanoMapper [31,113,114] databases. 
Conclusion 
There is a clear need to capture physicochemical and toxicological nanomaterial data 
in consistently organised, electronic datasets which can be integrated into online, 
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searchable databases to support predictive nanotoxicology. The generic ISA-TAB-
Nano specification serves as a useful starting point for constructing such datasets but 
additional guidance regarding how to capture different kinds of (meta)data, as 
reported in the nanotoxicology literature, as well as exactly which (meta)data to 
record in these datasets is required. The publicly available resources presented in 
the current publication are proposed as means of (partially) addressing these 
requirements as well as facilitating the creation of ISA-TAB-Nano datasets. These 
resources are data collection templates, corresponding business rules which extend 
the generic ISA-TAB-Nano specification, and Python code to facilitate parsing of 
these datasets and integration of these datasets within other nanoinformatics 
resources. Nonetheless, various challenges remain with standardised collection of 
data from the nanotoxicology literature which these resources cannot be claimed to 
have definitively solved such as the need for standardised recording of stepwise 
sample preparation and temporal information as well as the wider need to achieve 
community consensus regarding minimum information standards. Extension of these 
resources by the nanoinformatics community, ideally working closely with the 
nanotoxicology community, is anticipated to enhance their value. 
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Supporting Information 
Please note that in addition to the following Supporting Information files, which are 
versions of the “Toy Dataset” referred to in section 6, the templates and Python 
program described in this article are publicly available as previously explained 
[47,109,110]. 
 
Supporting Information File 1: 
File Name: TOY.article.resub.zip 
File Format: ZIP archive  
Title: “Toy Dataset” (i.e. not real data) created using the data collection templates 
 
Supporting Information File 2: 
File Name: TOY.article.resub-txt.zip 
File Format: ZIP archive  
Title: “TOY.article.resub.zip” converted using the Python program (default options) 
 
Supporting Information File 3: 
File Name: TOY.article.resub-txt_opt-a_opt-c.zip 
File Format: ZIP archive  
Title: “TOY.article.resub.zip” converted using the Python program (“-a”, “-c” options) 
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Supporting Information File 4: 
File Name: NanoPUZZLES_ISA-TAB-Nano-SupportingInformation-final.pdf 
File Format: PDF 
Title: Additional documentation and discussion 
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